1. Home
  2. VIR vs ADSE Comparison

VIR vs ADSE Comparison

Compare VIR & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ADSE
  • Stock Information
  • Founded
  • VIR 2016
  • ADSE 1980
  • Country
  • VIR United States
  • ADSE Ireland
  • Employees
  • VIR N/A
  • ADSE N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ADSE Industrial Specialties
  • Sector
  • VIR Health Care
  • ADSE Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • ADSE Nasdaq
  • Market Cap
  • VIR 706.4M
  • ADSE 581.6M
  • IPO Year
  • VIR 2019
  • ADSE N/A
  • Fundamental
  • Price
  • VIR $5.08
  • ADSE $9.85
  • Analyst Decision
  • VIR Strong Buy
  • ADSE
  • Analyst Count
  • VIR 10
  • ADSE 0
  • Target Price
  • VIR $26.80
  • ADSE N/A
  • AVG Volume (30 Days)
  • VIR 1.5M
  • ADSE 59.4K
  • Earning Date
  • VIR 10-30-2025
  • ADSE 09-12-2025
  • Dividend Yield
  • VIR N/A
  • ADSE N/A
  • EPS Growth
  • VIR N/A
  • ADSE N/A
  • EPS
  • VIR N/A
  • ADSE N/A
  • Revenue
  • VIR $19,000,000.00
  • ADSE $113,896,884.00
  • Revenue This Year
  • VIR N/A
  • ADSE $219.58
  • Revenue Next Year
  • VIR $9.65
  • ADSE N/A
  • P/E Ratio
  • VIR N/A
  • ADSE N/A
  • Revenue Growth
  • VIR N/A
  • ADSE 2.45
  • 52 Week Low
  • VIR $4.16
  • ADSE $9.00
  • 52 Week High
  • VIR $14.45
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • VIR 51.83
  • ADSE 38.21
  • Support Level
  • VIR $5.04
  • ADSE $9.82
  • Resistance Level
  • VIR $5.39
  • ADSE $10.45
  • Average True Range (ATR)
  • VIR 0.34
  • ADSE 0.76
  • MACD
  • VIR 0.05
  • ADSE -0.24
  • Stochastic Oscillator
  • VIR 49.20
  • ADSE 19.69

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: